Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.21%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +33.88%
#5 Humanity Humanity +26.25%
#6 Codatta Codatta +20.08%
#7 Walrus Walrus +18.11%
#8 Enso Enso +16.78%
#9 Collector Crypt Collector Crypt +14.74%
#10 The Black Bull The Black Bull +14.34%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rank in Stocks #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Share Price
$0.117
Last synced: 2025-04-04
Market Cap
$2.45M
Change (1 day)
-13.59%
Change (1 year)
0.00%
Country
US
Trade Carmell Therapeutics Corporation (CTCX)

Category

Healthcare
Number of shares outstanding for Carmell Therapeutics Corporation (CTCX)
Number of shares outstanding as of June 2026: 2.48M
According to Carmell Therapeutics Corporation latest financial reports and stock price the company's current number of shares outstanding is 2.48M. At the end of December 2023 the company had 20.77M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Carmell Therapeutics Corporation (CTCX) from 2021 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.48M -88.16%
2024 20.91M 0.64%
2023 20.77M 5.08%
2022 19.77M 0.00%
2021 19.77M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 10,157.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 2,412.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE